Testing for respiratory viruses and SARS‐CoV‐2 in clinical and epidemiological settings has contrasting purposes and utility. Symptomatic patients are best tested with respiratory virus panels to establish the pathogen and… Click to show full abstract
Testing for respiratory viruses and SARS‐CoV‐2 in clinical and epidemiological settings has contrasting purposes and utility. Symptomatic patients are best tested with respiratory virus panels to establish the pathogen and guide personalized treatment. Asymptomatic patients are tested for a single infectious pathogen to establish carrier status and guide containment.
               
Click one of the above tabs to view related content.